Company intelligence

MTVA

MetaVia Inc. · NASDAQ · Healthcare

Price$1.74+2.35% · +$0.04

Market cap3.83MEquity value

P / E-1.1Trailing ratio

Volume608.11KLatest session

Market data

MTVA price chart

TradingView

Related signals

1 min delayed

Browse public MTVA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

MTVAFeb 13, 2026-9.89% since signal

MetaVia Secures Dozens Of Patents Through 2041 For Obesity Drug

MetaVia Inc. (NASDAQ: MTVA) shares increased in premarket trading following the disclosure of a strong global intellectual property portfolio that supports its lead asset, DA-1726. This development could significantly boost the asset's attractiveness in the market, potentially influencing future revenue growth and investor sentiment.

View signal analysis

Research